Abstract
p-[bis(chloro-2-ethyl)amino]-L-phenylalanine (melphalan) is an approved anti-cancer agent with a broad spectrum of antitumor activity. However, it has some disadvantages, such as poor water-solubility followed by rapid elimination, which reduce the target specificity. To solve these problems, porphyrin- poly(amidoamine) or PAMAM-conjugates of melphalan were synthesized and characterized. The dendrimeric conjugates showed satisfactory water solubility. It was found that the size of the dendrimer played a crucial role in controlling the drug content and diameter of the melphalan-conjugates. The in vitro studies of cell cytotoxicity revealed that by employing the dendrimeric conjugation strategy and using the PAMAM dendritic arms as spacers, the conjugates had good anti-cancer activity and lower toxicity than free melphalan.
Acknowledgements
We would like to thank Rios O. H., Velasco L., Huerta S. E., Patiño M. M. R., Peña Gonzalez M. A., Rios Ruiz L. F. García-Hernández, F. Jaimes-Miranda and García Rios E. for technical assistance.
Disclosure statement
No potential conflict of interest was reported by the authors.